Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: Evidence from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)

Atherosclerosis

Volumn 180, Issue 2, 2005, Pages 381-388

  Gaw, Allan ^a   Murray, Heather M ^b   Brown, E Ann ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cardiovascular disease; Elderly; Lipoprotein(a)

Indexed keywords

LIPOPROTEIN A; PRAVASTATIN;

AGE DISTRIBUTION; AGED; ANAMNESIS; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GEOMETRY; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; STROKE; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; AGING; ANTICHOLESTEREMIC AGENTS; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; COHORT STUDIES; DISABLED PERSONS; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; PRAVASTATIN; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 23044437618     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.12.015     Document Type: Article

References (31)

1. J.W. Gaubatz, C. Heideman, A.M. Gotto Jr., J.D. Morrisett, and G.H. Dahlen Human plasma lipoprotein [a]: structural properties J Biol Chem 258 1983 4582
2. G. Utermann Lipoprotein(a) C.R. Scriver A. Beaudet W.S. Sly D. Valle The metabolic basis of inherited disease 1995 McGraw Hill Inc. New York 1887 1912
3. A. Gaw, and H.H. Hobbs Molecular genetics of lipoprotein (a): new pieces to the puzzle Curr Opin Lipidol 5 1994 149
4. J.J. Albers, J.L. Adolphson, and W.R. Hazzard Radio-immunoassay of human plasma Lp(a) lipoprotein J Lipid Res 18 1977 331
5. C. Sandholzer, N. Saha, and J.D. Kark Apo(a) isoforms predict risk for coronary heart disease Arteriosclerosis Thrombosis 12 1992 1214
6. G.G. Rhoads, G.H. Dahlén, K. Berg, N.E. Morton, and A.L. Dannenberg Lp(a) lipoprotein as a risk factor for myocardial infarction J Am Med Assoc 256 1986 2540
7. A.G. Bostom, L.A. Cupples, and J.L. Jenner Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study J Am Med Assoc 276 1996 544
8. V.W. Armstrong, P. Cremer, and E. Eberle The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis: dependence on serum LDL levels Atherosclerosis 62 1986 249
9. G.H. Dahlén Lipoprotein(a), atherosclerosis and thrombosis Prog Lipid Res 30 1991 189
10. A. Rosengren, L. Wilhelmsen, E. Eriksson, B. Risberg, and H. Wedel Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle-aged men Brit Med J 301 1990 1248
11. E.J. Schaefer, S. Lamon-Fava, and J.L. Jenner Lipoprotein(a) levels and risk of coronary heart disease in men. The Lipid Research Clinics Coronary Primary Prevention Trial J Am Med Assoc 271 1994 999
12. P. Cremer, D. Nagel, and B. Labrot Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS) Eur J Clin Invest 24 1994 444
13. M. Jauhiainen, P. Koskinen, and C. Ehnholm Lipoprotein(a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants Atherosclerosis 89 1991 59
14. M.S. Nieminen, K.J. Mattila, and K. Aalto-Setälä Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease Arterioscler Thromb 12 1992 58
15. P.M. Ridker, C.H. Hennekens, and M.J. Stampfer A prospective study of lipoprotein(a) and the risk of myocardial infarction J Am Med Assoc 270 1993 2195
16. K. Kario, T. Matsuo, and M. Imiya Close relation between lipoprotein (a) levels and atherothrombotic disease in Japanese subjects >75 years of age Am J Cardiol. 73 1994 1187
17. K. Kario, T. Matsuo, H. Kobayashi, R. Asada, and M. Matsuo 'Silent' cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high Lp(a) levels in elderly Japanese Arterioscler Thromb Vasc Biol 16 1996 734
18. G. Zenker, P. Koltringer, and G. Bone Lipoprotein(a) as a strong indicator for cerebrovascular disease Stroke 17 1986 942
19. S. Shintani, S. Kikuchi, H. Hamaguchi, and T. Shiigai High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction Stroke 24 1993 965
20. P.M. Ridker, M.J. Stampfer, and C.H. Hennekens Plasma concentration of lipoprotein(a) and the risk of future stroke J Am Med Assoc 273 1995 1269
21. A.A. Ariyo, C. Thach, and R. Tracy Lp(a) lipoprotein, vascular disease, and mortality in the elderly N Engl J Med 349 2003 2108
22. T.T. Nguyen, R.D. Ellefson, and D.O. Hodge Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women Circulation 96 1997 1390
23. V. Solfrizzi, F. Panza, and A. D'Introno Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease J Neurol Neurosurg Psychiat 72 2002 732
24. K. Urakami, T. Mura, and K. Takahashi Lp(a) lipoprotein in cerebrovascular disease and dementia Jpn J Psychiatry Neurol 41 1987 743
25. C. Sarti, L. Pantoni, and G. Pracucci Italian longitudinal study on aging (ILSA). Lipoprotein(a) and cognitive performances in an elderly white population: cross-sectional and follow-up data Stroke 32 2001 1678
26. J. Shepherd, G.J. Blauw, and M.B. Murphy Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial Lancet 360 2002 1623
27. I. Ford, G.J. Blauw, and M.B. Murphy A prospective study of pravastatin in the elderly at risk (PROSPER): screening experience and baseline characteristics Curr Controlled Trials Cardiovasc Med 3 2002 8
28. P.J. Houx, J. Shepherd, and G.J. Blauw Testing cognitive function in elderly populations: the PROSPER study J Neurol Neurosurg Psychiat 73 2002 385
29. A. Gaw, Gourlay CWD, E.A. Brown, and M.A. Bell Evaluation of a new automated latex agglutination assay for lipoprotein (a): comparison with a manual ELISA Clin Chim Acta 261 1997 175
30. A. Gaw, E. Boerwinkle, J.C. Cohen, and H.H. Hobbs Comparative analysis of the apo(a) gene, apo(a) glycoprotein and plasma concentrations of Lp(a) in three ethnic groups - evidence for no common "null" allele at the apo(a) locus J Clin Invest 93 1994 2526
31. D. Benedetto, E. Caglioti, and V. Loreto Language trees and zipping Phys Rev Lett 88 2002 0476702 04767021